|
Showing the most relevant articles for your search:NASDAQ:EDGE Date | Time | Source | Headline | Symbol | Company | 03/27/2024 | 2:52PM | iHub Newswire | FeaturedPOET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks | | |
03/18/2019 | 6:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:59PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:57PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:54PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:44PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:40PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 5:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/18/2019 | 7:31AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/15/2019 | 5:13PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/08/2019 | 5:24PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/04/2019 | 5:30PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/04/2019 | 5:29PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
03/04/2019 | 5:25PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/25/2019 | 5:03PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/22/2019 | 5:23PM | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/21/2019 | 4:21PM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/21/2019 | 3:36PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/21/2019 | 6:33AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/21/2019 | 6:15AM | GlobeNewswire Inc. | Edge Therapeutics Announces Full Year 2018 Financial Results | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/15/2019 | 2:35PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/15/2019 | 6:09AM | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/13/2019 | 11:02AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/11/2019 | 11:18AM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/04/2019 | 5:11PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
02/04/2019 | 5:10PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:EDGE | Edge Therapeutics, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:EDGE |
|